Intended for healthcare professionals


NICE approves drugs for Alzheimer's disease

BMJ 2001; 322 doi: (Published 27 January 2001) Cite this as: BMJ 2001;322:190
  1. Zosia Kmietowicz
  1. London

    Health authorities and trusts in England and Wales have been told to end the rationing of drugs to treat Alzheimer's disease and to make them available to all patients in whom they might slow the progression of the disease.

    The National Institute for Clinical Excellence (NICE) last week issued guidance on the drugs donepezil (Aricept), rivastigmine (Exelon), and galantamine (Reminyl), saying that drug treatment should now form one component of care in people with mild to moderate symptoms.

    Treatment …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription